Radice Law Firm is one of class counsel for direct purchaser plaintiffs in an antitrust action alleging a scheme by Sanofi to foreclose competition in the market for insulin glargine through improper Orange Book listings of device patents. The case is in discovery in the District of Massachusetts following the First Circuit’s remand in February 2020.